Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group: real-world observations
Objectives - The German quality assurance program (QS-Ovar) representatively documents treatment and survival for patients with the initial diagnosis of primary ovarian cancer in the third quarters of 2004, 2008, 2012, 2016, and 2021. We evaluate lymphadenectomy (LNE) rates in dependence on histolog...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 2025
|
| In: |
European journal of surgical oncology
Year: 2025, Jahrgang: 51, Heft: 6, Pages: 1-10 |
| ISSN: | 1532-2157 |
| DOI: | 10.1016/j.ejso.2025.109696 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejso.2025.109696 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0748798325001246 |
| Verfasserangaben: | Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Jalid Sehouli, Sven Mahner, Nikolaus de Gregorio, Lars Hanker, Florian Heitz, Frederik Marmé, Linn Wölber, Laura Holtmann, Gabriele Elser, Philipp Harter, for the AGO Study Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1933369833 | ||
| 003 | DE-627 | ||
| 005 | 20250913141845.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250818s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejso.2025.109696 |2 doi | |
| 035 | |a (DE-627)1933369833 | ||
| 035 | |a (DE-599)KXP1933369833 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wimberger, Pauline |d 1971- |e VerfasserIn |0 (DE-588)121614859 |0 (DE-627)705574733 |0 (DE-576)292800061 |4 aut | |
| 245 | 1 | 0 | |a Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group |b real-world observations |c Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Jalid Sehouli, Sven Mahner, Nikolaus de Gregorio, Lars Hanker, Florian Heitz, Frederik Marmé, Linn Wölber, Laura Holtmann, Gabriele Elser, Philipp Harter, for the AGO Study Group |
| 264 | 1 | |c June 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 15. Februar 2025, Artikelversion: 5. März 2025 | ||
| 500 | |a Gesehen am 18.08.2025 | ||
| 520 | |a Objectives - The German quality assurance program (QS-Ovar) representatively documents treatment and survival for patients with the initial diagnosis of primary ovarian cancer in the third quarters of 2004, 2008, 2012, 2016, and 2021. We evaluate lymphadenectomy (LNE) rates in dependence on histologic subtype and outcome for early ovarian cancer FIGO I. - Methods - Therapy quality was defined according to national guidelines. Surgical quality was categorized as “optimal“ (SUR+: maximum 1 surgical item missing), versus “suboptimal“ (SUR-); analogous categorization “optimal“ systemic treatment (CT+) and “suboptimal“ (CT-). - Results - Overall, 832 pts. (19.3 %) were diagnosed with FIGO I, of them 47.6 % with FIGO IC, 35.7 % had a high-grade serous subtype, 5.0 % low-grade serous, 6.9 % low-grade endometrioid, 18 % high-grade endometrioid, 11 % clear cell, and 18 % mucinous tumors. The optimal surgical standard increased from 21.1 % (2004) to 53.0 % (2012). Surgical quality has remained unchanged in 2021 with 53.8 % and SUR + -subgroup with 74.2 %. The rate of pelvic and para-aortic lymphadenectomy increased over time for high-grade serous and clear cell carcinoma and decreased for mucinous carcinoma. In 2021, 67.6 % had ≥25 resected lymph-nodes in high-grade serous, 46.2 % in low-grade serous, 52.2 % in high-grade endometrioid, 35.3 % in low-grade endometrioid, 74.1 % in clear cell and 35.7 % in mucinous tumors. In 2021, the SUR+/CT + -subgroup decreased to 62.9 % versus 69.2 % in 2016. Four-year-disease-free-survival was 86 % for SUR+/CT+, 78 % for SUR-/CT+, 68 % for SUR+/CT- and 57 % for SUR-/CT- (p < 0.001). - Conclusions - One therapy modality cannot replace another one. Although urgently required, quality of therapy has not improved in 2021. | ||
| 700 | 1 | |a Pfisterer, Jacobus |e VerfasserIn |4 aut | |
| 700 | 1 | |a du Bois, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hilpert, Felix |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kerkmann, Markus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sehouli, Jalid |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mahner, Sven |e VerfasserIn |4 aut | |
| 700 | 1 | |a de Gregorio, Nikolaus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hanker, Lars |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heitz, Florian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marmé, Frederik |d 1974- |e VerfasserIn |0 (DE-588)132561972 |0 (DE-627)52394893X |0 (DE-576)299226549 |4 aut | |
| 700 | 1 | |a Wölber, Linn |e VerfasserIn |4 aut | |
| 700 | 1 | |a Holtmann, Laura |e VerfasserIn |4 aut | |
| 700 | 1 | |a Elser, Gabriele |e VerfasserIn |4 aut | |
| 700 | 1 | |a Harter, Philipp |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of surgical oncology |d Burlington, Mass. : Harcourt, 1995 |g 51(2025), 6, Artikel-ID 109696, Seite 1-10 |h Online-Ressource |w (DE-627)320420361 |w (DE-600)2002481-2 |w (DE-576)103746862 |x 1532-2157 |7 nnas |a Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group real-world observations |
| 773 | 1 | 8 | |g volume:51 |g year:2025 |g number:6 |g elocationid:109696 |g pages:1-10 |g extent:10 |a Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group real-world observations |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejso.2025.109696 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0748798325001246 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250818 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 132561972 |a Marmé, Frederik |m 132561972:Marmé, Frederik |d 60000 |d 61300 |d 50000 |e 60000PM132561972 |e 61300PM132561972 |e 50000PM132561972 |k 0/60000/ |k 1/60000/61300/ |k 0/50000/ |p 11 | ||
| 999 | |a KXP-PPN1933369833 |e 4758596204 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"disp":"Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group real-world observationsEuropean journal of surgical oncology","titleAlt":[{"title":"EJSO"}],"note":["Gesehen am 05.02.20"],"origin":[{"dateIssuedDisp":"1995-","publisherPlace":"Burlington, Mass.","publisher":"Harcourt","dateIssuedKey":"1995"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"European journal of surgical oncology","title_sort":"European journal of surgical oncology"}],"part":{"issue":"6","year":"2025","text":"51(2025), 6, Artikel-ID 109696, Seite 1-10","pages":"1-10","extent":"10","volume":"51"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["Nachgewiesen 21.1995 -"],"recId":"320420361","id":{"issn":["1532-2157"],"eki":["320420361"],"zdb":["2002481-2"]}}],"id":{"eki":["1933369833"],"doi":["10.1016/j.ejso.2025.109696"]},"name":{"displayForm":["Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Jalid Sehouli, Sven Mahner, Nikolaus de Gregorio, Lars Hanker, Florian Heitz, Frederik Marmé, Linn Wölber, Laura Holtmann, Gabriele Elser, Philipp Harter, for the AGO Study Group"]},"physDesc":[{"noteIll":"Illustrationen","extent":"10 S."}],"recId":"1933369833","origin":[{"dateIssuedDisp":"June 2025","dateIssuedKey":"2025"}],"note":["Online veröffentlicht: 15. Februar 2025, Artikelversion: 5. März 2025","Gesehen am 18.08.2025"],"title":[{"title_sort":"Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group","subtitle":"real-world observations","title":"Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"given":"Pauline","role":"aut","family":"Wimberger","display":"Wimberger, Pauline"},{"family":"Pfisterer","display":"Pfisterer, Jacobus","given":"Jacobus","role":"aut"},{"family":"du Bois","display":"du Bois, Andreas","given":"Andreas","role":"aut"},{"family":"Hilpert","display":"Hilpert, Felix","given":"Felix","role":"aut"},{"family":"Kerkmann","display":"Kerkmann, Markus","given":"Markus","role":"aut"},{"given":"Jalid","role":"aut","display":"Sehouli, Jalid","family":"Sehouli"},{"given":"Sven","role":"aut","display":"Mahner, Sven","family":"Mahner"},{"role":"aut","given":"Nikolaus","family":"de Gregorio","display":"de Gregorio, Nikolaus"},{"role":"aut","given":"Lars","family":"Hanker","display":"Hanker, Lars"},{"role":"aut","given":"Florian","display":"Heitz, Florian","family":"Heitz"},{"family":"Marmé","display":"Marmé, Frederik","given":"Frederik","role":"aut"},{"given":"Linn","role":"aut","family":"Wölber","display":"Wölber, Linn"},{"given":"Laura","role":"aut","display":"Holtmann, Laura","family":"Holtmann"},{"given":"Gabriele","role":"aut","display":"Elser, Gabriele","family":"Elser"},{"given":"Philipp","role":"aut","family":"Harter","display":"Harter, Philipp"}]} | ||
| SRT | |a WIMBERGERPIMPACTOFLY2025 | ||